Difference between revisions of "Template:Antiparkinson agents"
Jump to navigation
Jump to search
blackwiki>Manifestation m ("Antiparkinson" -> "Antiparkinson medication") |
m (53 revisions imported) |
||
| (6 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name = Antiparkinson | + | | name = Antiparkinson agents |
| − | | title = [[ | + | | title = [[Management of Parkinson's disease#Medication|Antiparkinson agents]] ([[ATC code N04|N04]]) |
| state = {{{state<includeonly>|autocollapse</includeonly>}}} | | state = {{{state<includeonly>|autocollapse</includeonly>}}} | ||
| listclass = hlist | | listclass = hlist | ||
| Line 10: | Line 10: | ||
| group1 = [[Dopamine|DA]] [[Precursor (chemistry)|precursor]]s | | group1 = [[Dopamine|DA]] [[Precursor (chemistry)|precursor]]s | ||
| list1 = | | list1 = | ||
| − | * [[Levodopa]]<sup>#</sup> | + | * [[L-DOPA|Levodopa]]<sup>#</sup> |
* [[Melevodopa]] | * [[Melevodopa]] | ||
| − | | group2 = [[Dopamine receptor|DA receptor]] [[Dopamine | + | | group2 = [[Dopamine receptor|DA receptor]] [[Dopamine agonist|agonist]]s |
| list2 = | | list2 = | ||
* [[Apomorphine]] | * [[Apomorphine]] | ||
| Line 29: | Line 29: | ||
| list3 = | | list3 = | ||
* [[Rasagiline]] | * [[Rasagiline]] | ||
| + | * [[Safinamide]] | ||
* [[Selegiline]] | * [[Selegiline]] | ||
| − | | group4 = [[Catechol-O- | + | | group4 = [[Catechol-O-methyltransferase|COMT]] [[COMT inhibitor|inhibitor]]s |
| list4 = | | list4 = | ||
* [[Entacapone]] | * [[Entacapone]] | ||
| Line 67: | Line 68: | ||
| group3 = Others | | group3 = Others | ||
| list3 = | | list3 = | ||
| − | * [[Amantadine]]<!--Controversial--> | + | * [[Amantadine]]<!-- Controversial --> |
* [[Budipine]] | * [[Budipine]] | ||
| − | * [[Methylxanthine]]s (e.g., [[caffeine]]) | + | * [[Xanthine|Methylxanthine]]s (e.g., [[caffeine]]) |
| − | * [[Rimantadine]]<!--Off-label, and controversial--> | + | * [[Rimantadine]]<!-- Off-label, and controversial --> |
| list4 = | | list4 = | ||
Latest revision as of 14:22, 22 October 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Antiparkinson agents|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Antiparkinson agents|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Antiparkinson agents|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.